BeStock  
Stocks › Medical Devices › LIVN

LivaNova LIVN

US equityMarket cap rank #2056Medical DevicesBrain-Computer Interface
$90.73 −$1.34 (-1.46%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $90.73 0.00%
Open$91.50
Prev close$92.07
Day range$90.15 – $93.16
Volume536.7K
Market cap$5.00B
P/E (TTM)26.0
Dividend yield–

Earnings

Average move on report day±9.4%last 16 reports
Closed higher10 of 1663% of the time
Best reaction+23.7%
Worst reaction-15.8%

Stock move on the day after each report

+8.0%2023/Q4+12.3%2024/Q1-3.7%2024/Q2-3.1%2024/Q3-15.8%2024/Q4+23.7%2025/Q1+11.1%2025/Q2-5.8%2025/Q3+1.8%2025/Q4+15.1%2026/Q1-8.4%2026/Q2+17.9%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q34 Nov 2026Pre Market±9.0%+17.88%Bigger than priced
2026/Q25 Aug 2026Pre Market±7.9%-8.41%Bigger than priced
2026/Q16 May 2026Pre Market±9.7%+15.05%Bigger than priced
2025/Q425 Feb 2026Pre Market±9.5%+1.80%Within range
2025/Q35 Nov 2025Pre Market±11.3%-5.80%Within range
2025/Q26 Aug 2025Pre Market±8.7%+11.15%Bigger than priced
2025/Q17 May 2025None±9.3%+23.72%Bigger than priced
2024/Q425 Feb 2025None–-15.76%–
2024/Q330 Oct 2024Pre Market±11.6%-3.08%Within range
2024/Q231 Jul 2024Pre Market±10.1%-3.70%Within range
2024/Q11 May 2024Pre Market±10.1%+12.32%Bigger than priced
2023/Q421 Feb 2024Pre Market–+8.02%–
2023/Q31 Nov 2023Pre Market±10.6%+2.02%Within range
2023/Q226 Jul 2023None±12.1%+9.87%Within range
2023/Q13 May 2023Pre Market±12.0%+0.79%Within range
2022/Q422 Feb 2023Pre Market±11.5%-10.92%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Cardiopulmonary$225.30M 57.3%
  • Neuromodulation$166.13M 42.3%
  • Other revenue$1.72M 0.4%

Latest reported quarter: Q3, ended Sep 2026

Revenue$393.15M+9.9% YoY
Operating profit$28.43M-47.4% YoY
Net profit$34.29M+28.0% YoY
Diluted EPS$0.11-77.6% YoY
Free cash flow$42.89M-31.0% YoY
Operating cash flow$73.66M

Revenue, last 8 quarters

$321.8MDec '24$316.9MMar '25$352.5MJun '25$357.8MSep '25$360.9MDec '25$362.3MMar '26$390.6MJun '26$393.1MSep '26

Net profit, last 8 quarters

$55.9MDec '24$-327.3MMar '25$27.2MJun '25$26.8MSep '25$30.9MDec '25$22.3MMar '26$108.6MJun '26$34.3MSep '26

Profitability & balance sheet

Gross margin67.8%
Operating margin10.7%
Net margin13.0%
Return on equity15.5%
Return on assets7.4%
Return on invested capital12.2%
Current ratio1.46
Liabilities / assets49.4%
Cash & investments$563.47M
Total debt$347.88M
Net cash (debt)$215.58M
Free cash flow / sales8.6%

Discussion

No comments yet — be the first to weigh in on LIVN.

Sign in to join the discussion.

Scroll to Top